Imvanex
What Imvanex is used for
Active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in individuals 2 years of age and older. The use of this vaccine should be in accordance with official recommendations.
Approved use, as published by the European Medicines Agency.
What the labels mean
- Approved under exceptional circumstances: full data cannot be collected, usually because the disease is very rare.
Key facts
- Brand
- Imvanex
- Active substance
- smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara)
- Disease area
- Smallpox Vaccine; Monkeypox virus
- Medicine group
- Other viral vaccines
- ATC code
- J07BX
- Marketing authorisation holder
- Bavarian Nordic A/S
- Authorised in the EU since
- 2013
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Imvanex used for?
Active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in individuals 2 years of age and older. The use of this vaccine should be in accordance with official recommendations.
What is the active substance in Imvanex?
Imvanex contains smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara).
Who makes Imvanex?
The EU marketing authorisation holder is Bavarian Nordic A/S.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU